Robinhood

ARK has reshuffled its fund positions: sales included Robinhood, Teradyne and DraftKings, while purchases focused on AI infrastructure (CoreWeave, Cerebras), defense and aerospace (Kratos, AeroVironment, Intuitive Machines, Joby) and biotech therapeutics (Intellia, Recursion, Nurix). Investments in autonomous driving (WeRide, Pony AI, Kodiak AI) were also increased, while providers of genomic tools were reduced. The reallocations come even though rising yields on US government bonds weigh on growth-oriented stocks and ARK only publishes its trades after market close. » More on finanzen.net

ARK Invest sold a total of 63,466 Robinhood shares (about $7.24 million), representing only 0.05–0.10 percent of the funds’ assets each, and concurrently bought 97,639 CoreWeave shares (approx. $8.53 million). The partial sales appear to be a reallocation after price gains; Robinhood’s quarterly results on October 27 will be decisive for its valuation. The CoreWeave purchases reflect ARK’s positive view of demand for AI compute capacity, but investors should note the company’s high volatility and debt. » More on finanzen.net

Robinhood allows U.S. customers to create their own AI agents in the app that can buy and sell stocks and will soon run automated strategies (“Loops”). Users choose models such as OpenAI or Anthropic; model use is free through the end of the year, after which compute and data subscription fees will apply. Agents trade by default in separate subaccounts and normally require manual transaction approvals, but that approval can be turned off so orders can be placed autonomously. Experts warn of higher volatility risks from autonomous systems; Robinhood cautions that customers bear the full risk of trades executed by AI agents. » More on handelsblatt.com